Hypertensive complications in pregnancy are the leading cause of maternal morbidity, at least in the developed countries. In recent years, infertility issues are managed with ever growing therapeutic options namely assisted reproductive technologies (ART), which improve the ratio of successful induction of pregnancy. It is still debated whether various ART modalities are associated with adverse pregnancy outcomes, including hypertensive complications, particularly with higher incidence of preeclampsia. The main source of controversy stems from the diversity of effect modifiers modulating the association between ART-oriented pregnancy and hypertensive disorders. Indeed, women undergoing an ART procedure are affected by diverse causes of infertility, are frequently characterized by different genetic patterns with respect to their artificially conceived embryo and experienced multiple gestations. In order to investigate whether ART modalities are associated with increased incidence of hypertensive complications in pregnancy, we reviewed all published studies carried out before the end of 2010 and identified in the PubMed database. Among the 47 studies finally selected and by acknowledging the potential of shortcomings related to the different study design and populations, the overall evidence suggests that ART-oriented pregnancies---especially the in-vitro fertilization techniques---are accompanied by increased risk for gestational hypertension and preeclampsia as compared with non-ART pregnancies, even after adjustment for confounders. Multiple gestations, advanced age and underlying polycystic ovary syndrome resulted in constant confounders of the questioned association. Reducing multiple gestations by implementing single embryo techniques might be the therapeutic limiting step to lower the rate of hypertensive complications in assisted pregnancies.
INTRODUCTION
Demand for assisted reproductive technology (ART) has increased steadily in the last 30 years, among infertile couples and proved effective in achieving considerable rates of successful artificial conception, as well as outstanding live birth rates of up to 39% for women younger than 35 years. 1 However, the various modalities of ART (Table 1) continue to be an object of criticism due to potential adverse obstetric and perinatal outcomes.
Hypertension disorders occurring in 8 --10% of pregnancies represent the leading cause of obstetric complications. 2, 3 In previous studies that investigated the association of ART with obstetric outcomes including hypertensive disorders, it remained unclear whether either ART itself or other co-existing risk factors (that is, maternal age, parity, fetal multiplicity, chronic hypertension, genetic differences among women with artificial insemination including gamete or embryo transplantation) were independent contributors to morbid events in this population. 4 In the present paper, we aimed to investigate through a systematic review of the literature whether ART modalities increase or not the incidence of hypertensive complications in pregnancy. Furthermore, we review the available literature on pathophysiology and causal relationship of ART and hypertensive complications and how the current evidence could be translated in clinical decision making in women undergoing ART-oriented pregnancy.
METHODS
In order to evaluate available evidence regarding the incidence of hypertensive complications in ART-initiated pregnancies, we reviewed all published studies carried out before the end of 2010. Studies were identified in PubMed Database by implementing the primary search terms 'gestational hypertension', 'preeclampsia', 'pregnancy-induced hypertension' and 'chronic hypertension' paired respectively with the following: 'assisted reproductive technology'; 'in vitro fertilization (IVF)'; 'clomiphene citrate'; 'superovulation'; 'gamete intrafallopian transfer'; 'in vivo fertilization'; 'zygote intrafallopian transfer'; 'artificial insemination'; 'cryopreservation'; 'intracytoplasmic sperm donation'; 'embryo donation'; and 'oocyte donation'. During the screening process, we excluded studies not in human, not in English language, and review articles, letters to the Editor (not containing primary data), case series, editorial articles, commentaries and case reports. Thereafter, duplicate articles were removed in a two-step fashion: the first between the primary keyword category and the second between the paired-oriented searching categories. The remaining eligible for analysis articles were searched for relevance (determined by the title and abstract section) and all qualifying articles were selected for retrieval and copying. Authors then read and reviewed the abstraction list to determine relevance of the studies for the purposes of this review. In reading the articles, we checked the reference lists to identify any other articles that may have been relevant to the research question or provided additional information. The first and second author of the present manuscript reviewed independently all articles at each stage and discrepancies were resolved by consensus. The whole literature search strategy is summarized in the Supplementary file (Supplementary Table S1 ).
RESULTS

Study selection
Using the consequential procedure described above and in Supplementary Table S1 , 50 studies were found to be eligible for analysis in this article. Thirty-six of these articles resulted from the paired searching term 'gestational hypertension and assisted reproductive technology', nine remained unduplicated within the combined term 'preeclampsia and assisted reproductive technology', three in the term 'gestational hypertension and IVF', one in 'gestational hypertension and intracytoplasmic sperm donation', and finally one in 'gestational hypertension and clomiphene citrate'. By reviewing the reference list of these 50 articles, we further identified four relevant additional articles for the purposes of this review. Among these 54 articles, we excluded seven that did not investigate directly the association between the ART procedure and obstetric outcomes, including hypertensive complications in pregnancy. Finally, 47 articles were selected for the primary purpose of this review and are presented in Table 2 .
Association of ART with hypertensive disorders in pregnancy: epidemiological overview It is postulated that pregnancies achieved through ART, as compared with spontaneously conceived pregnancies are at higher risk for obstetric and fetal complications. However, it remains unclear whether the resulting risk is attributable to either the underlying infertility cause or clinical and genetic characteristics of the infertile couple or even of the use of ART modalities per se. 5 Numerous studies so far, have evaluated the effect of ART on hypertensive complications in pregnancy (Table 2) , 6 --52 but some of them included inappropriate control groups and reported no data of potential confounding variables. Furthermore, since heterogeneity of clinical characteristics of the participants could have affected the results, it is difficult to distinguish the crude effect of ART treatment on the examined undesired hypertensive outcome. Although the exact etiology of hypertensive disorders in pregnancy is still not definitive, several factors have been incriminated as promoters of adverse outcome such as primiparity, advanced age, gestational diabetes, chronic hypertension and multiple gestations. However, these factors are common in women undergoing ART treatment and consequently may represent undesirable accelerators of the relationship between ART and hypertensive disorders.
Among studies having adjusted for maternal age, parity and multiple gestations, some found an increased risk for hypertensive disorders in women receiving infertility treatments after full stepwise stratification 8, 11, 14, 17, 19, 37 restriction to singletons 7, 10, 12, 40 and multiple gestations. 6, 13, 22, 41, 43, 44 In contrast, others failed to find significant differences between assisted and spontaneous pregnancies after full stratification, 45 restriction to singletons 38, 42, 46 and multiple gestations. 48, 49 Another hidden issue not accounted for the increased incidence of gestational hypertension in ART pregnancies might be the influence of donated gametes 24 highlighting the potential impact of maternal and fetal genetic component in the complex etiology of hypertensive disorders in pregnancy.
More conclusive associations can be obtained from the subset of the prospective studies. The first and second trimester risk (FASTER) trial 7 estimated the risk of preeclampsia in three groups of women: 554 who had an invasive ART procedure (that is, IVF, intracytoplasmic sperm injection, gamete intrafallopian transfer or zygote intrafallopian transfer); 1222 who had a non-invasive ART procedure (that is, ovulation induction or intrauterine insemination); and 34 286 who conceived normally. Only singleton pregnancies were considered and extensive adjustment for maternal characteristics was performed. FASTER trial concluded that invasive ART is associated with 2.7-fold increased risk of preeclampsia compared with no-ART. By contrast, non-invasive ART failed to predict preeclampsia, suggesting that invasive ART per se might contribute to the development of preeclampsia. In another prospective study the screening for pregnancy endpoints (SCOPE), 15 small for gestational age infants were classified according to whether their mothers were normotensive or developed hypertensive complications. IVF subgroup of pregnancies was a significant predictor of the small for gestational age complicated by gestational hypertension phenotype. Among 48 IVF pregnancies examined prospectively 18 fetal multiplicity con- ART pregnancy and hypertensive disorders C Thomopoulos et al tributed in an incremental manner to the development of hypertensive complications. In the specific area of oocyte donation 30 introduced by gamete intrafallopian transfer, the incident preeclampsia was 38% among 61 participants. Interestingly, 38% among preeclamptic women had age 442 years. Along the same lines, Katalinic et al. 50 in a large prospective controlled cohort demonstrated that intracytoplasmic sperm injection or frozen embryo transfer as ART modalities for initiating a pregnancy was characterized by heighten risk for gestational hypertension or preeclampsia as compared with normally conceived pregnancies. By contrast, in a small prospective series of 90 consecutive pregnancies conceived by IVF compared with non-IVF pregnancies and multiple natural conceived pregnancies, it was shown that IVF modality was not associated with higher incidence of hypertensive complications with respect to the control groups. 45 In summary, the overall weight of evidence (Table 2) suggests that ART treatment of infertility is predictive of hypertensive complications in pregnancy and traditional confounders represent crucial determinants that could alleviate the magnitude of the positive association. 9 However, it is yet unknown whether the remaining positive association after adjustment for potential confounders might be faded if ART-induced genetic differences between parents and fetus (that is, donation aspects of ART), or infertility issues have been taken into account.
Comparative evaluation of specific infertility treatments on pregnancy-related hypertensive complications Several studies have been conducted to evaluate the possible differences of specific infertility treatments on gestational hypertension rates. A higher risk of gestational hypertension was found among women undergoing IVF compared with women receiving ovulation induction treatment. 7, 8, 10 In a recent study, Chen et al. 8 examined the association of special procedures of infertility and preeclampsia. They showed that women who opted for IVF demonstrated an almost 80% increased risk for preeclampsia, whereas those who opted for both intrauterine insemination and ovulation induction did not show any increased risk. In contrast, Sun et al. 38 observed that intrauterine insemination was associated with an almost twofold risk for preeclampsia attributable to the use of donor sperm. Katalinic et al. 50 in a prospective cohort study, demonstrated that women who conceived after intracytoplasmic sperm injection as compared with those who conceived naturally had a 30% higher risk for preeclampsia, whereas Källé n's et al.
14 found a tendency for fewer complications in women who received intracytoplasmic sperm injection as compared with those undergoing standard IVF. These results are likely due to the different characteristics of women receiving standard IVF compared with those receiving intracytoplasmic sperm injection, such as the lower rate of fertility in the latter case and that intracytoplasmic sperm injection is generally used because of paternal infertility.
SPECIFIC ASPECTS: EFFECT MODIFIERS
Maternal age and parity Women undergoing an ART procedure are older and primiparous, both conditions that could affect the incidence of obstetric complications. Age represents a risk factor for hypertensive disorders and more specifically the risk of preeclampsia increases by 30% per year over the age of 34 years. 53 Paulson et al. 54 reported that the incidence of preeclampsia escalates to 60% in women older than 55 years. Furthermore, nulliparity almost triples the risk of preeclampsia 55, 56 and women with preeclampsia have a double risk to be nulliparous as compared with women without preeclampsia. 57 Therefore, age and parity could potentially modify the incidence of hypertensive disorders in pregnancy, but even In parenthesis is reported the 95% confidence interval; incident outcome is reported as %.
ART pregnancy and hypertensive disorders C Thomopoulos et al after controlling for these confounders their cumulative impact is not enough to specifically reverse the increased risk of obstetric complications in the IVF pregnancies. 37 Multiple gestations The worldwide incidence of twin births among IVF pregnancies is almost 27%. 58 Since 1980, the number of twin births raised dramatically by 77% and three-fourths of the latter increase is attributed to infertility treatments including IVF. 59 It has been hypothesized that the majority of obstetric and neonatal complications after ART might be the result of multiple gestations. Indeed, Sibai et al. 60 reported twofold increase in the rate of hypertensive disorders among women with twin gestation as compared to those with singleton gestation. Lynch et al. 6 argued that women experiencing multiple ART gestations are at double risk for developing preeclampsia as compared with spontaneously conceived women. Along the same lines, Källé n et al.
14 found no increase in hypertensive disorders when he compared multiple IVF with multiple non-IVF pregnancies. Finally, in the study of Hernández-Díaz et al., 37 the relative risk for gestational hypertension in IVF pregnancies declined from 80 to 30% after adjustment for parity, body adiposity and multiple gestations. By acknowledging the differences in the study design, random variations within the studies and differences between the clinical characteristics in the studied population, the effect of multiple gestations in ART pregnancies should be considered as a major confounder for the hypertensive-oriented outcomes.
In addition, some studies emphasize the existence of higher hypertensive disorder rates even when singleton pregnancies are considered separately. Maman et al. 10 concluded that singleton pregnancies conceived by IVF and ovulation induction demonstrated a twofold and 1.5-fold increased risk for hypertensive disorders respectively, as compared with normally conceived women. They attributed their findings to the hormonal milieu induced by either the implemented ART modality, or the adverse preexisting metabolic and vascular state of women undergoing IVF. In a metaanalysis from Jackson et al., 61 the risk for preeclampsia among singleton pregnancies after IVF was found increased. Accordingly, it has been hypothesized that the increased risk is more likely to be attributed to the high proportion of the resulting singletons after therapeutically eliminating twins or triplets. 62 The impairment of fetal growth as a residual effect of fetal reduction might correspond to either placental insufficiency from damage at the time of fetal elimination or abnormal implantation in multiple initial endometrial sites of invasion. 63 However, other studies have not consistently observed adverse sequelae from the early elimination of one twin. 64 Obesity Studies focusing on the role of body mass index on pregnancy outcomes have implemented different cutoff value for the definition of increased body size. Although, the evidence so far indicates that the risk of hypertensive complications in pregnancy is increased in a dose-related manner with increasing of body adiposity 65 surprisingly, in the IVF-initiated pregnancies obesity was an innocent bystander of preeclampsia development. 66, 67 By contrast, Hernández-Díaz et al. 37 in ART pregnancies demonstrated that the risk for hypertensive complications almost doubles and triples for women with body mass index between 20 and 27 and 427 kg m --2 , respectively, in comparison with the reference group of women with body mass index below 20 kg m --2 . The findings of the later study are not confirmed in a previous systematic review focused on ART outcomes and body size. 68 In summary, increased body size before pregnancy impacts ART pregnancies in the same extent with respect to those spontaneously conceived.
Anteconception hypertension There are no comparative studies in ART conceiving women with and without preexisting hypertension, evaluating the incidence of hypertensive complications later in pregnancy. Sympathetic overdrive and hyperactivated renin-angiotensin-aldosterone system in preexisting hypertension may adversely affect obstetric outcomes in pregnancies both spontaneously conceived and ARToriented. Additionally, hypertension as an inflammatory vascular disease, theoretically might contribute adversely to the pathophysiological hormonal-inflammatory milieu induced by the implemented ART modalities. 10 However, the latter hypothetical view should be evaluated in prospective or even retrospective case --control studies.
Maternal reactivity to donated gametes: the desensitization theory Multiple genetic and immune factors resulting in fetal allograft intolerance may limit implantation and may promote hypertension in pregnancy. Increased incidence of preeclampsia was observed in pregnancies resulting from donated sperm compared with naturally conceived pregnancies, reflecting the importance of maternal reactivity versus desensitization to paternal antigens, which is non-existent in sperm donation. 24 --26 In a large mixed cohort of pregnancies those based on donor insemination demonstrated incident preeclampsia of 9.3% almost double than the expected rate. 28 Moreover, the risk of preeclampsia in women with primary infertility and donated sperm was almost 25% compared with almost 7% of their age-matched counterparts who conceived with their partner's sperm. 27 By contrast, a further study suggested that hypertensive complications in pregnancy are not associated with lack of previous exposure to paternal antigens; however, reported data are confined to antenatal gestational proteinuric hypertension, which excluded a significant proportion of hypertension disorders in pregnancy. 51 By the side of ovum donation pregnancies, the risk of hypertensive disorders was higher compared with spontaneously conceived women after adjustment for age and parity. 24 However, other studies added contradictory results in the same setting, but did not account for age, parity and order of gestation. 29, 30, 36, 69 In women over 38 years, IVF pregnancies with donor oocytes compared with IVF pregnancies with autologous oocytes demonstrated a similar risk of preeclampsia, suggesting that the effect of ova donation is not the triggering factor for incident hypertensive disorders. 31 Taken together the above, ova donation pregnancies are at higher risk for hypertensive disorders, but after adjustment for traditional confounders the proposed association seems to weaken.
In the combined version of gamete donation, namely embryo donation where the entire fetal genome results allogenic, the incidence of preeclampsia is highly augmented as compared with normally conceived pregnancies. 24 The latter highlights the importance of the allogenic genetic substrate implemented in the ART techniques, as an accelerator of hypertensive complications in pregnancy.
In summary, during ART procedures, genetic factors may constitute obscured levers for immune activation and subsequent adverse hypertensive-oriented outcome. Since the genetic theory of preeclampsia is biologically plausible, more studies are needed to clarify that issue in light of both the updated immune-oriented and the partly genetically triggered pathophysiological hypothesis of preeclampsia. 70 Causes of infertility A higher risk of gestational hypertension has been reported among patients with polycystic ovary syndrome (PCOS) after ovulation induction. 9 In that retrospective study, 9 PCOS women received ovulation induction as an ART to become pregnant and were compared with non-PCOS infertile women who received superovulation associated with intacytoplasmic sperm injection or IVF with frozen embryo transfer. Surprisingly, PCOS women although did not undergo invasive ART demonstrated a 10-fold risk for preeclampsia as compared with non-PCOS women who opted for an invasive ART. Additionally, gestational hypertension in the setting of PCOS is more frequently associated with heighten insulin resistance compared with uncomplicated pregnancies. 71 In a metaanalysis evaluating the incidence of hypertensive disorders in women opted for conventional IVF, it is not reported whether those with PCOS compared with those without experienced higher risk. 72 A subsequent metaanalysis in the same setting 73 demonstrated that the risk of either preeclampsia or gestational hypertension was almost fourfold higher in PCOS compared with non-PCOS. Although, the latter study omitted the relationship of PCOS with the modality of conception, it is clear that PCOS women received diverse ART therapeutic approaches that could have contributed to the adverse hypertension-oriented outcome.
ART AND PREECLAMPSIA: PATHOPHYSIOLOGICAL ASPECTS
The clinical manifestation of preeclampsia is influenced by maternal, genetic and environmental factors confirming its multifactorial inheritance. 74 In ART procedures accompanied by fetal multiplicity uteroplacental blood flow is compromised, and diminished blood flow represents a critical parameter for triggering obstetric complications. Additionally, since ART procedures are generally applicable to women of advanced age or even to those affected by various infertility causes, the already established endothelial dysfunction is at least of intermediate intensity.
In ART pregnancies, there is evidence that transfer of the conceptus into the uterine cavity through uterine cervix and the effect of altered hormonal environment in the endometrium may both interfere with the development of maternal --fetal interface resulting in placental insufficiency. Furthermore, the increasing incidence of placenta previa among IVF pregnancies may also result from embryos transfer techniques and inadequate implantation of the embryos in the lower part of the uterus. Daniel et al. 75 found that placentas after ART had significantly higher weight, increased incidence in abnormal shapes and thick appearance as compared with placentas from non-ART pregnancies. Growth restriction in multiple gestations further promotes increased placental debris and increased antigenic load. Last but not least, in IVF pregnancies the formation of the chorion is initiated in vitro, thus the inherent difference in the nature of the placenta itself may predispose to abnormal placentation, diseased placenta vessels and inadequate uteroplacental circulation, conditions that conjointly or separately may contribute to the ART-mediated hypertensive phenotype.
The observation that prior exposure to the partner's semen protects against the development of preeclampsia suggested that immunologic factors might participate to abnormal placental development. 27, 76, 77 Some of the ART modalities possess the potential of disrupting the usual maternal tolerability to paternal antigens, though driving toward a disruption of the normal mechanisms responsible for the protection of fetoplacental unit from rejection (allograft) or an aberrant immunological response directed against placental-specific antigens. Additionally, a systematic review 78 reflected no clear evidence that several specific human leukocyte antigen alleles are involved in the pathogenesis of preeclampsia and it was suggested that the interaction between maternal and fetal human leukocyte antigen system rather than any individual genotype alone triggers the immunogenetic mechanism of preeclampsia under the modulating role of placental oxidative stress. 70 Finally, a common pathophysiological denominator between ART procedures and preeclampsia might be identified in the breach of the relative balance between vasoactive factors. 79 Indeed, in IVF procedures without the formation of corpus luteum, there is a deficiency in relaxin that may result in impaired vasodilation and heighten vascular dysfunction. 80 
CLINICAL IMPLICATIONS
Primary prevention of hypertensive disorders in pregnancy includes treatment of known risk factors, such as obesity, insulin resistance, anteconception hypertension and fetal multiplicity. Restricting the number of embryos transferred during IVF increases the proportion of singleton births. In 2009, the revised guidelines of the American Society of Reproductive Medicine 81 suggested limiting the number of embryos transferred, based upon maternal age and embryo quality for cryopreservation.
Well-designed, adequately powered prospective studies should address the question of whether the obstetric outcomes of ART pregnancies are different from that of non-ART conceptions. Although in the studies so far maternal age, parity, obesity and multiple gestations were used as traditional effect modifiers for testing the above question, genetic differences and causes of infertility should be monitored and implemented as further potential determinants in the design of the future studies.
CONCLUSIONS
Multiple ART pregnancies are accompanied by higher risk of hypertensive complications with respect to singleton ART pregnancies that in turn are characterized by heighten hypertension risk compared with normally conceived singletons. Advanced maternal age, anteconception hypertension and endothelial dysfunction may further contribute to the higher incidence of hypertensive complications in ART-oriented pregnancies. Specific infertility causes such as PCOS potentially accelerate the association between an ART implemented modality and the development of preeclampsia. Finally, the altered genetic and immune substrate may have a crucial role in the observed hypertensive phenotypes among ART pregnancies. Lastly, placenta seems more compromised and deteriorated in ART compared with normal pregnancies, a finding that adversely favors maternal vascular dysfunction and increased hemodynamic load in the ART subset of pregnant women.
In the context of ART procedures, the main objective, which is the successful induction of pregnancy, should be accompanied by a non-complicated course and outcome. Amelioration of the implemented ART techniques in the direction of singleton pregnancies in closely monitored women may diminish hypertensive complications.
